Prevalence of osteoporosis in patients with prostate cancer on anti-androgen therapy

被引:0
|
作者
Senan Sanz, M. R.
Haro Iniesta, L.
Riel Cabrera, R.
Olive Ferre, F. X.
Biel Arrufat, A.
Matinero Romero, E.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:151S / 151S
页数:1
相关论文
共 50 条
  • [21] Hormone-refractory prostate cancer? Anti-androgen withdrawal and intermittent hormone therapy
    Sciarra, A
    Casale, P
    Colella, D
    Di Chiro, C
    Di Silverio, F
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1999, 33 (04): : 211 - 216
  • [22] Prostate cancer risk after anti-androgen treatment for priapism
    Tabitha Goetz
    Arthur L. Burnett
    International Urology and Nephrology, 2014, 46 : 757 - 760
  • [23] RTOG 9601: SALVAGE RT & ANTI-ANDROGEN THERAPY IN PROSTATE CANCER PATIENTS WITH ELEVATED PSA AFTER SURGERY
    Shipley, W. U.
    Hunt, D.
    Lukka, H.
    Heney, N.
    Major, P.
    Grignon, D.
    Patel, M.
    Bahary, J. P.
    Lawton, C.
    Sandler, H.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S219 - S219
  • [24] Anti-androgen hormonal therapy for cancer and other diseases
    Student, Sebastian
    Hejmo, Tomasz
    Poterala-Hejmo, Aleksandra
    Lesniak, Aleksandra
    Buldak, Rafal
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 866
  • [25] Prostate cancer risk after anti-androgen treatment for priapism
    Goetz, Tabitha
    Burnett, Arthur L.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (04) : 757 - 760
  • [26] A TRIAL OF ANTI-ANDROGEN THERAPY FOR BREAST-CANCER
    BREWIN, TB
    CLINICAL ONCOLOGY, 1983, 9 (02): : 179 - 180
  • [27] STEROID-LEVELS IN CANCER OF THE PROSTATE - MARKERS OF TUMOR DIFFERENTIATION AND ADEQUACY OF ANTI-ANDROGEN THERAPY
    GELLER, J
    ALBERT, J
    LOZA, D
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1979, 11 (01): : 631 - 636
  • [28] Comparison of longitudinal changes in bone mineral density in advanced prostate cancer patients treated with androgen ablation or anti-androgen hormonal therapy
    Wadhwa, V
    Weston, R
    Hussain, A
    Parr, NJ
    JOURNAL OF UROLOGY, 2005, 173 (04): : 221 - 221
  • [29] Re: Redirecting Abiraterone Metabolism to Fine-Tune Prostate Cancer Anti-Androgen Therapy
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 196 (05): : 1447 - 1447
  • [30] Identification of favorable subgroups for alternative anti-androgen therapy in castration-resistant prostate cancer
    Suzuki, Kotaro
    Terakawa, Tomoaki
    Shigemura, Katsumi
    Furukawa, Junya
    Harada, Kenichi
    Hinata, Nobuyuki
    Nakano, Yuzo
    Fujisawa, Masato
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 11 (05) : 523 - 530